Best VCs for Clinical Trials

4 venture capitalists actively investing in Clinical Trials.

Active VCs

Funds

Deals

Founding General Partner

Norrsken VC

Tove backs ambitious European technology companies whose commercial growth directly improves outcomes for people or planet. Her Bain private-equity background and early impact roles add rigorous marke

Norrsken VC currently states €1M–€10M early-stage and growth tickets. This is the firm's range, not Tove's personal promise. Confirm initial ticket, follow-on reserves, ownership and stage with the team.

Early StageSeedSeries A

#2Christian zu Jeddeloh

Former Investment Manager

Norrsken Impact Fund

During his Norrsken tenure, Christian explored frontier technologies where difficult physical environments create enabling infrastructure for Earth: satellites for climate intelligence, microgravity f

Historical Norrsken role. The firm now publishes €1M–€10M tickets, but no personal ticket or present investing authority should be inferred because Christian left for an operating role in 2026.

Historical: SeedHistorical: Series APortfolio Operations

#3Hayley Barna

Partner

First Round Capital

Hayley backs very early founders tackling real-world systems—especially healthcare, climate, supply chain, and commerce—that have been overlooked or written off as unsolvable. As a former founder, she

First Round's published firm-wide initial checks are typically $1M–$7M, averaging about $3.5M; it has participated in rounds from $100K to $20M. No personal range is published for Hayley.

AngelPre-SeedSeed

#4Jun Jeon

Partner

Khosla Ventures

Jun backs long-horizon technologies at the intersection of biology, healthcare and frontier engineering. His medical training, decade of bench and clinical research, digital-health operating work and

No reliable current personal check range was found. Khosla Ventures invests across company stages and is known for both early technical risk and later follow-on support, but founders should ask Jun about the applicable vehicle, initial ownership, reserves and decision process rather than relying on marketplace estimates.

Company FormationSeedSeries A

Explore more sectors

All Sectors Clinical Trials Investments All VCs